MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):189-192. doi: 10.15585/mmwr.mm7006a1.
At its October 2020 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the 2021 Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger. After Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration (FDA), ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedule. After Emergency Use Authorization of Moderna COVID-19 vaccine by FDA, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2).
在 2020 年 10 月的会议上,免疫实践咨询委员会* (ACIP) 批准了 2021 年推荐的 18 岁以下儿童和青少年免疫接种时间表。在食品和药物管理局 (FDA) 紧急授权辉瑞-生物技术公司的 COVID-19 疫苗后,ACIP 在 2020 年 12 月 12 日的会议上发布了一项关于在 16 岁及以上人群中使用辉瑞-生物技术公司 COVID-19 疫苗的临时建议(1)。此外,ACIP 批准了一项修正案,将 COVID-19 疫苗建议纳入儿童和青少年免疫接种时间表。在 FDA 紧急授权 Moderna COVID-19 疫苗后,ACIP 在 2020 年 12 月 19 日的紧急会议上发布了一项关于在 18 岁及以上人群中使用 Moderna COVID-19 疫苗的临时建议(2)。